Nitazoxanide for sudden worsening of liver cirrhosis
Part of Digestive system clinical trials.
This trial tests whether a medication called nitazoxanide can help people with liver cirrhosis who have just had a sudden health decline. The goal is to prevent further liver failure and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cirrhosis (any cause).
- You had a sudden worsening of liver function in the last 10 days, such as fluid buildup in the belly, confusion, or bleeding in the digestive tract.
- You are an adult under age 75.
- You can swallow pills.
- You are not on dialysis and do not need a liver support machine.
- You have not taken nitazoxanide in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether an antiparasitic medicine called nitazoxanide can help treat a type of infection in the belly fluid that happens in people with liver cirrhosis. If you have cirrhosis and this infection, joining might give you access to a new treatment option.
This Phase 3 trial tests whether nitazoxanide can help stop hepatic encephalopathy (a “liver-to-brain” confusion problem) from coming back. It’s for adults with cirrhosis who have had at least one past episode, aiming to improve safety and prevent recurrence.
This study tests whether adding nitazoxanide, an anti-parasitic medicine, to your current ulcerative colitis treatment helps reduce inflammation and symptoms. It may offer an extra option for people with mild-to-moderate disease.
This trial tests whether the medicine nitazoxanide, taken as a pill, can help people with mild COVID-19 or flu feel better faster and prevent complications. It is designed for people who are generally healthy and can be treated at home.
This trial tests if a medication called nitazoxanide can help people with mild to moderate ulcerative colitis (UC). It may be a treatment option for those not already on strong UC medications.
This study tests a medicine called nitazoxanide to treat cryptosporidium, a germ that can cause diarrhea in children. If your child tests positive for this germ, the treatment may help clear the infection.
Hear when a new Acute Decompensation of Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.